Şunu aradınız:: bioequivalence (Danca - İngilizce)

investigation of bioavailability and bioequivalence
investigation of bioavailability and bioequivalence

note for guidance on the investigation of bioavailability and bioequivalence
note for guidance on the investigation of bioavailability and bioequivalence

section i (pharmacokinetic and clinical evaluation) clinical investigation of new vaccines investigation of bioavailability and bioequivalence
section i (pharmacokinetic and clinical evaluation)

testing and evaluation of the efficacy of antiparasitic substances for the treatment and prevention of tick and flea infestation in cats and dogs the conduct of bioequivalence studies for veterinary medicinal products efficacy of anthelmintics:specific recommendations for poultry efficacy of anthelmintics:specific recommendations for feline
guidelines/status conduct of pharmacokinetic studies in animals adopted march 2000 conduct of efficacy studies for intramammary products for use in cattle adopted march 2000 testing and evaluation of the efficacy of antiparasitic substances for the treatment and prevention of tick and flea infestation in cats and dogs adopted november 2000 the conduct of bioequivalence studies for veterinary medicinal products released for consultation january 2000 efficacy of anthelmintics:

emea's arbejdsgruppe vedrørende urtemedicin titel på dokumentet note for guidance on non-clinical testing of herbal drug preparations with long-term marketing experience -guidance facilitate mutual recognition and use of bibliographic data concept paper for a note for guidance on the investigation of biopharmaceutical characterisation and bioavailability/bioequivalence of herbal drugs/preparations position paper on the risk associated with the use of herbal products containing estragole position paper on the risk associated with the use of herbal products containing methyleugenol position paper on the risk associated with the use of herbal products containing á -and -asarone position paper on the use of sassafras albidum as active substance or ingredient in herbal medicinal products
note for guidance on non-clinical testing of herbal drug preparations with long-term marketing experience -guidance to facilitate mutual recognition and use of bibliographic dataconcept paper for a note for guidance on the investigation of biopharmaceutical characterisation and bioavailability/bioequivalence of herbal drugs/preparations position paper on the risk associated with the use of herbal products containing estragole position paper on the risk associated with the use of herbal products containing methyleugenol